Paschalis Barboutis
Research Subjects
Paschalis Barboutis has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Christina Dastamani
Pathology Laboratory, General Hospital of Karditsa, 43100 Karditsa, Greece
1 shared publication - Christos Michalakis
Department of Internal Medicine, General Hospital of Karditsa, 43100 Karditsa, Greece
1 shared publication - Dimitrios Mavrakis
Department of Urology, General Hospital of Karditsa, 43100 Karditsa, Greece
1 shared publication - Dimitrios Triantis
School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
1 shared publication - Theodoros Petranis
Department of Urology, General Hospital of Karditsa, 43100 Karditsa, Greece
1 shared publication
Latest Publications
- Open Access
- 26 September 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (10) , 994
CircRNAs and Erectile Dysfunction: A Hybrid Review of Possible Interactions
Erectile dysfunction (ED) is a prevalent condition involving multiple molecular mechanisms. Although non-coding RNAs have emerged as important regulators of gene expression, the role of circular RNAs (circRNAs) in ED remains poorly defined. CircRNAs are characterised by a covalently closed loop structure that confers enhanced stability and enables diverse regulatory functions. This review aims to investigate the potential interactions between circRNAs and the signalling pathways linked to ED. Only two primary studies directly investigating circRNA dysregulation in ED were identified, highlighting the early stage of this field. This hybrid systematic narrative review combines a PRISMA-guided systematic search with a pre-specified, hypothesis-generating narrative synthesis of the broader circRNA literature across key signalling pathways implicated in ED, including the NO/cGMP/PKG, RhoA/ROCK, JNK/c-Jun/Bak, and TNF-α/NF-κB axes. We identify several circRNAs as potential regulators of endothelial dysfunction, inflammation, and smooth muscle contractility. CircRNAs therefore emerge as candidate biomarkers and potential therapeutic targets. Given that direct evidence is currently limited to two animal studies, with no circRNA validated in human tissue or as a biomarker, these molecules should be regarded only as candidates for future biomarker and therapeutic target validation.
- 26 September 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (10) , 994
Open AccessCircRNAs and Erectile Dysfunction: A Hybrid Review of Possible Interactions
Erectile dysfunction (ED) is a prevalent condition involving multiple molecular mechanisms. Although non-coding RNAs have emerged as important regulators of gene expression, the role of circular RNAs (circRNAs) in ED remains poorly defined. CircRNAs are characterised by a covalently closed loop structure that confers enhanced stability and enables diverse regulatory functions. This review aims to investigate the potential interactions between circRNAs and the signalling pathways linked to ED. Only two primary studies directly investigating circRNA dysregulation in ED were identified, highlighting the early stage of this field. This hybrid systematic narrative review combines a PRISMA-guided systematic search with a pre-specified, hypothesis-generating narrative synthesis of the broader circRNA literature across key signalling pathways implicated in ED, including the NO/cGMP/PKG, RhoA/ROCK, JNK/c-Jun/Bak, and TNF-α/NF-κB axes. We identify several circRNAs as potential regulators of endothelial dysfunction, inflammation, and smooth muscle contractility. CircRNAs therefore emerge as candidate biomarkers and potential therapeutic targets. Given that direct evidence is currently limited to two animal studies, with no circRNA validated in human tissue or as a biomarker, these molecules should be regarded only as candidates for future biomarker and therapeutic target validation.